Division of Cardiology, Department of Medicine, Canada; Mazankowski Alberta Heart Institute, Canada.
Mazankowski Alberta Heart Institute, Canada; Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Canada.
Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1925-1937. doi: 10.1016/j.bbadis.2018.08.030. Epub 2018 Aug 26.
Iron metabolism is a balancing act, and biological systems have evolved exquisite regulatory mechanisms to maintain iron homeostasis. Iron metabolism disorders are widespread health problems on a global scale and range from iron deficiency to iron-overload. Both types of iron disorders are linked to heart failure. Iron play a fundamental role in mitochondrial function and various enzyme functions and iron deficiency has a particular negative impact on mitochondria function. Given the high-energy demand of the heart, iron deficiency has a particularly negative impact on heart function and exacerbates heart failure. Iron-overload can result from excessive gut absorption of iron or frequent use of blood transfusions and is typically seen in patients with congenital anemias, sickle cell anemia and beta-thalassemia major, or in patients with primary hemochromatosis. This review provides an overview of normal iron metabolism, mechanisms underlying development of iron disorders in relation to heart failure, including iron-overload cardiomyopathy, and clinical perspective on the treatment options for iron metabolism disorders.
铁代谢是一个平衡的过程,生物系统已经进化出了精密的调节机制来维持铁的稳态。铁代谢紊乱是一个全球性的广泛的健康问题,范围从缺铁到铁过载。这两种类型的铁代谢紊乱都与心力衰竭有关。铁在线粒体功能和各种酶功能中起着基本作用,缺铁对线粒体功能有特别的负面影响。鉴于心脏的高能量需求,缺铁对心脏功能有特别的负面影响,并会加重心力衰竭。铁过载可能是由于肠道过多地吸收铁或经常输血引起的,常见于先天性贫血、镰状细胞贫血和重型β地中海贫血患者,或原发性血色病患者。这篇综述提供了一个关于正常铁代谢的概述,以及铁代谢紊乱与心力衰竭发展相关的机制,包括铁过载心肌病,并对铁代谢紊乱的治疗选择进行了临床方面的讨论。